Therefore, the primary aim of the current proof‐of‐principle study was to investigate the effect of our previously applied PHA regimen on glucose metabolism and whole‐body insulin sensitivity as well as iHSP72 concentrations in overweight, middle‐aged men; a population at high risk for development of the metabolic syndrome and type 2 diabetes mellitus. Here, INS is linked to type 2 diabetes mellitus.